RESPAIR, INC.
AssuranceET, a pediatric endotracheal tube with micro-baffles replacing inflatable cuff balloons to seal the airway
- Sector
- Medtech
- Headquarters
- PITTSBURGH, PA
- Founded
- 2021
- Latest Form D
- $2.2M, Jun 2025
- Total capital
- $2.8M
- Federal grants
- $604K
- 2 awards · 2024–2025
- Rank in peer group#133 of 445
- Private capital raised
- $2.2M
- 1 Form D · last Jun 2025
- 17 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 2 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · AssuranceET: a novel endotracheal tube sealing mechanism to protect pediatric patients from airway trauma and collapse while empowering clinician decision-making.$305K
- Private capital raisedForm D · SEC · 1st filing$2.2M
- Federal grantHealth and Human S · Phase I · RelianceET: a novel endotracheal tube design with a superior sealing mechanism to improve clinical efficiency and reduce lung injury and infection for patients.$299K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
13months
from RESPAIR, INC.’s first federal award to its first private round.
- First federal award · Apr 2024
- Health and Human S · $299K
- First Form D · Jun 2025
- $2.2M · 1st Form D
- Awards before first raise
- 1 award
An association in public records, not a cause or a prediction.
Standing among 445 peers
Line = medianMedtech · Device
- Federal grants#133 · top 30%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Ross BeresfordResearcherExecutive Officer, Director, PromoterLinked by $604K in grants as PI
- Carl SnydermanExecutive OfficerNamed in SEC Form D filings
- Craig BellDirectorNamed in SEC Form D filings
- Garrett CoyanExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 2- PendingEndotracheal Tubes And Methods ThereofUSPTOApplication PCTUS2023010807
- PendingEndotracheal Tubes And Methods ThereofUSPTOApplication 19146024
Related companies, and why
- AVIOR, INC.Similar federal contract value in Medtech · null in contracts
- CROSSLINER INCSimilar federal contract value in Medtech · null in contracts
- Deurion R&D LLCSimilar federal contract value in Medtech · null in contracts
- GrailSimilar federal contract value in Medtech · null in contracts
- PARATECHS CORPSimilar federal contract value in Medtech · null in contracts
- Vital Connect, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .